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Objectives: It is unclear whether community treatment orders (CTOs) for people with severe 
mental illnesses can reduce health service use, or improve clinical and social outcomes. 
Randomized controlled trials of CTOs are rare because of ethical and logistical concerns. This 
meta-analysis updates available evidence.
Method: A systematic literature search was performed of the Cochrane Schizophrenia Group 
Register, Science Citation Index, PubMed, MEDLINE, and Embase to November 2013. 
Inclusion criteria were studies comparing CTOs with standard care including those where 
control subjects received voluntary care, for most of the trial.
Results: Three studies provided 749 subjects for the meta-analysis. Two compared 
compulsory treatment with entirely voluntary care, while the third had control subjects 
receiving voluntary treatment for the bulk of the time. Compared with control subjects, 
CTOs did not reduce readmissions (risk ratio 0.98, 95% CI 0.82 to 1.16) or bed days (mean 
difference [MD] –16.36; 95% CI –40.8 to 8.05) in the subsequent 12 months (n = 749). 
Moreover, there were no significant differences in psychiatric symptoms (standardized MD 
–0.03; 95% CI –0.25 to 0.19; n = 331) or the Global Assessment of Functioning (MD –1.36; 
95% CI –4.07 to 1.35; n = 335). Only including the 2 studies that compared compulsory 
treatment with entirely voluntary care made no difference to the results.
Conclusions: CTOs may not lead to significant differences in readmission, social functioning, 
or symptomatology, compared with standard care. Their use should be kept under review. 
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Une méta-analyse mise à jour des données probantes randomisées 
contrôlées de l’efficacité des ordonnances de traitement en milieu 
communautaire
Objectifs : Il n’a pas été déterminé si les ordonnances de traitement en milieu communautaire 
(OTMC) pour les personnes souffrant de graves maladies mentales peuvent réduire l’utilisation 
des services de santé, ou améliorer les résultats cliniques ou sociaux. Cette méta-analyse met 
à jour les données probantes disponibles.
Méthode : Une recherche systématique de la littérature a été menée dans les Cochrane 
Schizophrenia Group Register, Science Citation Index, PubMed, MEDLINE, et Embase 
jusqu’en avril 2013. Les critères d’inclusion étaient des études comparant les OTMC aux soins 
habituels, incluant celles où les sujets témoins ont reçu des soins sur un mode volontaire pour 
la majorité de l’essai.
Résultats : Trois études ont fourni 749 sujets à la méta-analyse. Deux comparaient le 
traitement obligatoire avec les soins entièrement volontaires tandis que la troisième avait des 
sujets témoins recevant des soins volontaires pour la majorité du temps. Comparé aux sujets 
témoins, les OTMC ne réduisaient pas les réhospitalisations (rapport de risques 0,98; IC à 95 % 
0,82 à 1,16) ni les journées-patients (différence moyenne [DM] –16,36; IC à 95 % –40,8 à 8,05) 
dans les 12 mois subséquents (n = 749). En outre, il n’y avait pas de différence significative 
des symptômes psychiatriques (DM normalisée –0,03; IC à  95 % –0,25 à 0,19; n = 331) ou 
de l’évaluation globale de fonctionnement (DM –1,36; IC à 95 % –4,07 à 1,35; n = 335). Inclure 
seulement les 2 études qui comparaient le traitement obligatoire avec les soins entièrement 
volontaires ne faisait pas de différence dans les résultats.
www.LaRCP.ca
562   W   La Revue canadienne de psychiatrie, vol 59, no 10, octobre 2014
Brief Communication
Abbreviations
CTO   community treatment order
GAF   Global Assessment of Functioning
MD   mean difference
OCTET   Oxford Community Treatment Order Evaluation Trial
RCT   randomized controlled trial
SMD   standardized mean difference
Clinical Implications
• RCTs of CTOs are rare because of ethical and logistical 
concerns. In such a situation of limited studies and 
participants, meta-analyses can help address the 
issue of insufficient power. This brief communication 
indicated that compulsory CTOs did not reduce hospital 
admissions or bed days in the subsequent 12 months, 
compared with RCT subjects. Moreover, there were no 
significant differences in psychiatric symptoms or the 
GAF.
• Any extension of the use of compulsory CTOs should 
be accompanied by further evaluation of effectiveness.
Limitations
• Only 3 studies were included; the generalizability of 
results to other jurisdictions is therefore unclear.
• All 3 studies in our review may have been subject to 
selection bias.
• There is debate as to whether 1 of the studies was a 
comparison of CTOs with voluntary care, or 2 types of 
compulsory treatment. However, excluding this study 
made no difference to the results.
There is controversy over whether CTOs can reduce health service use, or improve clinical outcome and 
social functioning. RCTs of CTOs are rare because of 
ethical and logistical concerns. To date, there have only 
been 3. Two from the United States compared court-ordered 
compulsory treatment with entirely voluntary care. Both 
were published 15 years ago, 1 from New York and the 
other from North Carolina.1–4 These 2 studies have been 
the subject of considerable debate. Both excluded patients 
with a history of dangerousness from randomization. 
Although understandable from a pragmatic and ethical 
standpoint, this limited generalizability as these patients 
may be the most likely candidates for CTOs. In the case of 
the New York study,1,2 a smaller than expected sample size 
and high attrition compromised study power. There were 
also concerns about adherence to the research protocol 
and apparent confusion among staff and patients that 
some in the control arm were on CTOs.5 A further issue 
was that both clinicians and police officers were reluctant 
to enforce compulsory community treatment.2 All these 
factors may therefore have led to an underestimation of 
the intervention’s effect.2 In the case of the North Carolina 
study, the RCT results were sometimes combined with 
those of an additional nonrandomized group of violent 
patients who were also placed on CTOs.3,4,6 In addition, 
the significant effects on bed days in nonrandomized 
analyses of extended outpatient committal received greater 
prominence than those of the primary RCT, where there 
were no differences in outcomes. Attrition was also higher 
for some of the secondary outcomes.
In a situation of limited studies and participants, meta-
analyses can help address the issue of insufficient power. 
A Cochrane review of the 2 RCTs published at the time, 
both from the United States (n = 416), found no differences 
between CTO patients and control subjects in health service 
use, psychiatric morbidity, or social functioning.5
A subsequent study from England was known as the 
OCTET.7 OCTET was a study of clinician-initiated, rather 
than court-ordered, treatment studied in the American 
RCTs and thus more relevant to other jurisdictions, such as 
Australia, Canada, and New Zealand. The study randomized 
patients discharged from hospital to an experimental 
group (CTO) or a control group (leave under Section 17 
of the Mental Health Act), comparing their outcomes at 12 
months. Section 17 allows patients to leave the hospital for 
days or even months while still subject to recall.8 Although 
the length of initial compulsory outpatient treatment 
differed significantly between the 2 groups (medians 
of 183 days, compared with 8 days), Section 17 patients 
averaged 4 months on some form of compulsory treatment 
over the course of the study. Unlike the US studies, patients 
with a history of violence were not excluded. However, 
patients were only included if they were thought to be 
equally suitable for a relatively short Section 17 or a CTO. 
Patients who may have especially benefited from a CTO 
may therefore have been excluded.8 Further, around 20% 
of eligible patients lacked capacity to consent or refused to 
participate. Finally, treating clinicians were able to make 
decisions independent of randomization, thus around one-
fifth of patients in either arm swapped treatments.
Uncertainty about whether OCTET was a comparison 
of CTOs with voluntary care, or 2 types of compulsory 
treatment, meant that the results of this trial were not 
combined with the other 2 in the update of the Cochrane 
review currently under progress.
However, an alternative view is that Section 17 patients 
were on voluntary treatment for the bulk of follow-up and 
results could be included with those of the other 2 studies. 
Therefore, our paper presents the effect of combining the 
Conclusions : Les OTMC n’entraînent pas nécessairement de différences significatives 
des réhospitalisations, du fonctionnement social ou de la symptomatologie, 
comparativement aux soins réguliers. Leur utilisation devrait être sous revue.
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OCTET study with the relevant outcomes from the other 
2 studies.
Method
We undertook a systematic literature search of the Cochrane 
Schizophrenia Group Register, Science Citation Index, 
PubMed, MEDLINE, and Embase to November 2013. 
Inclusion criteria were RCTs that compared compulsory 
CTOs with standard care, including studies where control 
subjects received voluntary care for most of the trial. The 
primary outcomes were readmission and bed days during 
12 months of follow-up. Secondary ones were psychiatric 
morbidity and social functioning during the same period. 
Data extraction was conducted by 2 independent researchers.
We assessed the quality of included studies using the 
following criteria of the risk of bias assessment tool, 
developed by the Cochrane Collaboration: selection bias; 
blinding; attrition bias; and, reporting bias.9
We calculated the mean differences for continuous data 
where studies used the same scale for each outcome, and 
the standardized mean difference for data that used different 
scales. We assessed heterogeneity using the I2 statistic, a 
measure that does not depend on the number of studies in 
the meta-analysis and hence has greater power to detect 
heterogeneity when the number of studies is small. We used 
the random effects model given the heterogeneity of the 
data.
Results
Figure 1 shows the results of the systematic review. Five 
papers from 3 studies provided 749 subjects for the meta-
analysis. Two from the United States compared compulsory 
treatment with entirely voluntary care,1–4 while the third, 
from England, had control subjects who received voluntary 
treatment for an average of around 8 out of the 12 months 
of follow-up.7
The quality of the included studies was not optimal, 
reflecting the pragmatic nature of such effectiveness trials 
with only 1 study meeting at least 3 of the 4 quality criteria.7 
Attrition was low for the 2 primary outcomes (15%), but 
higher for secondary ones (30%).
All 3 studies reported on hospital readmission and bed days 
(n = 749). We combined these results using the risk ratio 
and MD, respectively. Two studies included the results 
Figure 1  Selection of randomized controlled trials (RCTs) for inclusion 
in the systematic review and meta-analysis
Screening of titles and abstracts 
n = 143
Full -text articles reviewed for eligibility
n = 63
RCTs included in qualitative synthesis  
n = 15 articles from 3 studies
Excluded, n = 80  
 not an intervention trial 
 no control subjects 
 not randomized 
 not a study of compulsory community treatment
Excluded, n = 65  not an intervention trial  no control subjects  not randomized  not a study of compulsory community treatment
Potential articles identified through database screening 
n = 7366
Records excluded, n = 7283 
RCTs included in meta-analysis
n = 5 articles from 3 studies 
Excluded, n = 10  Outcomes that were not updated in the Oxford 
Community Treatment Order Evaluation Trial study 

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of psychiatric rating scales, the Positive and Negative 
Syndrome Scale and the Brief Psychiatric Rating Scale 
(n = 331), which we combined using SMD.1,7 They also 
reported results from the GAF scale (n = 335), which were 
combined using the MD.1,7 In 3 analyses, the I2 was 0%. 
However, for bed days, it was 73%.
Compared to control subjects, CTOs did not reduce 
readmissions (Figure 2) or bed days (MD –16.36; 95% 
CI –40.8 to 8.05) in the subsequent 12 months (n = 749), 
and there were no significant differences in psychiatric 
symptoms (SMD –0.03; 95% CI –0.25 to 0.19; n = 331) or 
the GAF (MD –1.36; 95% CI –4.07 to 1.35; n = 335).
Discussion
Given the logistical and ethical difficulties of undertaking 
RCTs in this area, it is important to maximize the use of 
existing RCT evidence. Inclusion of the OCTET study 
almost doubled the number of participants available for 
meta-analyses, compared with the earlier Cochrane review.5 
In addition, the form of compulsory CTOs in the OCTET 
study was more similar to that found in Canada, compared 
with the 2 studies from the United States.
The most obvious limitation is the small number of studies; 
the generalizability of results to other jurisdictions is, 
therefore, unclear. Another is uncertainty about the voluntary 
or compulsory status of the control subjects in the OCTET 
study, which will doubtless be the subject of ongoing debate. 
However, meta-analyses restricted to the 2 studies comparing 
compulsory treatment with entirely voluntary care gave 
similar results.5,10 A further issue in all 3 RCTs was selection 
bias. Depending on the study, patients with a history of 
dangerousness were excluded,1–4 and around 20% of eligible 
patients lacked capacity to consent to the study, or refused to 
take part.7 In addition, attrition was higher for the secondary 
outcomes of psychiatric morbidity and social functioning. 
Finally, the bed days analysis should be interpreted with 
caution, given significant statistical heterogeneity.
Bearing these limitations in mind, our results suggest that 
CTOs may not lead to significant differences in readmission, 
social functioning, or symptomatology, compared with 
standard care. Accordingly, there remains sufficient 
uncertainty about CTOs to warrant further large RCTs 
that would compare CTO patients with voluntary control 
subjects. Ideally, these should have multiple outcomes 
and sufficient numbers for adequate statistical power, and 
be undertaken in jurisdictions with well-established CTO 
programs.
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Figure 2  Readmission in the 12 months of follow-up
Risk ratio Risk ratio
Study or subgroup Events Total Events Total
Weight 
%
M-H Random  
95% CI
M-H Random  
95% CI
Swartz et al3 56 129 66 135 42.9 0.89 (0.68 to 1.15)
Steadman et al1 40 85 27 67 21.7 1.17 (0.81 to 1.69)
Burns et al7 59 166 60 167 35.4 0.99 (0.74 to 1.32)
Total (95% CI) 380 369 100.0 0.98 (0.82 to 1.16)
Total events 155 153
Heterogeneity: τ2 = 0.000; χ2 = 1.42; df = 2; P = 0.49; I2 = 0%
Test for overall effect: Z = 0.24; P = 0.81
M-H = Mantel-Haenszel
ControlTreatment
Favours treatment        Favours control
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